Business
VMS Rehab Systems Inc. Reports On New Senior Management Appointments At Its BioPharmcor Generic Drug Unit
VMS Rehab Systems Inc. Reports On New Senior Management Appointments At Its BioPharmcor Generic Drug Unit.
About this update from Vms Rehab Systems
[{"type":"text","content":"\n\n\n\nVMS Rehab Systems Inc. Reports On New Senior Management Appointments At Its BioPharmcor Generic Drug Unit\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nVMS Rehab Systems Inc. Reports On New Senior Management Appointments At Its BioPharmcor Generic Drug Unit\nPR Newswire\nOTTAWA, Ontario, March 10, 2016\n\n\n\nOTTAWA, Ontario, March 10, 2016 /PRNewswire/ -- VMS Rehab Systems Inc. (www.vmsrehabsystemsinc.com) announced today that the Company's BioPharmcor generic drug subsidiary has successfully expanded its roster of 'best of class' human capital to steer its generic drug business forward in the months and years ahead.  Over the past 2 quarters, the Company has filled a number of key positions in both its European and North American operations.\n\nAt BioPharmcor BV, Amsterdam, The Netherlands, the parent Company of the BioPharmcor Group,  Robert J. Wassink RA, has been designated as the Company's Chief Financial Officer(CFO). \n\nRobert Wassink brings to BioPharmcor over 20 years of corporate business experience in finance, general management, asset, liability and enterprise risk management, corporate governance, strategy and project management.  Mr. Wassink is a multilingual certified Dutch CPA (1998) with national and international expertise providing corporate financial management in The Americas, Europe, Asia Pacific, the Middle East and the Caribbean.\n\nPrior to taking on the CFO responsibilities at the BioPharmcor Group, Mr. Wassink served as the Chief Financial Officer, Aruba Bank NV, the largest commercial bank in Aruba. In addition, he has held senior management positions at Deloitte Accountants, Amsterdam and HLB Schippers Tax and Legal Advisors, Amsterdam (currently BDO). Mr. Wassink is a principal of Bula Consulting, Amsterdam through which he provides his services to BioPharmcor and other clients.\n\nAt BioPharmcor Inc, a newly created Canadian subsidiary of BioPharmcor BV, Dr. Stuart Madden, PhD, CChem, FRSC will serve as BioPharmcor's Vice President, Pharmaceutical Development.\n\nDr. Madden has over 3...